Serum interleukin-15 level is a useful predictor of the complications and mortality in severe acute pancreatitis

Surgery

Volumn 142, Issue 3, 2007, Pages 319-326

  Ueda, Takashi ^a   Takeyama, Yoshifumi ^b   Yasuda, Takeo ^a   Shinzeki, Makoto ^a   Sawa, Hidehiro ^a   Nakajima, Takahiro ^a   Takase, Kozo ^a   Matsumoto, Ippei ^a   Fujita, Tsunenori ^a   Ajiki, Tetsuo ^a   Fujino, Yasuhiro ^a   Kuroda, Yoshikazu ^a  

^a KOBE UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE PANCREATITIS; ADULT; APACHE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ACUTE DISEASE; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-15; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NECROSIS; PANCREAS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SURVIVAL RATE; TIME FACTORS;

EID: 34548127749     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.05.002     Document Type: Article

References (35)

1. Tenner S., Sica G., Hughes M., Noordhoek E., Feng S., Zinner M., et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 113 (1997) 899-903
2. Buter A., Imrie C.W., Carter C.R., Evans S., and McKay C.J. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 89 (2002) 298-302
3. Beger H.G., Bittner R., Block S., and Buchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91 (1986) 433-438
4. Buchler M.W., Gloor B., Muller C.A., Friess H., Seiler C.A., and Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232 (2000) 619-626
5. Ueda T., Takeyama Y., Yasuda T., Shinzeki M., Sawa H., Nakajima T., et al. Immunosuppression in patients with severe acute pancreatitis. J Gastroenterol 41 (2006) 779-784
6. Takeyama Y., Takase K., Ueda T., Hori Y., Goshima M., and Kuroda Y. Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J Gastrointest Surg 4 (2000) 379-387
7. Ueda T., Takeyama Y., Yasuda T., Takase K., Nishikawa J., and Kuroda Y. Functional alterations of splenocytes in severe acute pancreatitis. J Surg Res 102 (2002) 161-168
8. Ueda T., Takeyama Y., Yasuda T., Matsumura N., Sawa H., Nakajima T., et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol 41 (2006) 158-165
9. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994) 965-968
10. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180 (1994) 1395-1403
11. Burton J.D., Bamford R.N., Peters C., Grant A.J., Kurys G., Goldman C.K., et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91 (1994) 4935-4939
12. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13 (1994) 2822-2830
13. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14 (1995) 3654-3663
14. Armitage R.J., Macduff B.M., Eisenman J., Paxton R., and Grabstein K.H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154 (1995) 483-490
15. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2 (1996) 175-182
16. Liu Z., Geboes K., Colpaert S., D'Haens G.R., Rutgeerts P., Ceuppens J.L., et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 164 (2000) 3608-3615
17. Suzuki J., Morimoto S., Amano H., Tokano Y., Takasaki Y., Hashimoto H., et al. Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 28 (2001) 2389-2391
18. Aringer M., Stummvoll G.H., Steiner G., Koller M., Steiner C.W., Hofler E., et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 40 (2001) 876-881
19. Kakumu S., Okumura A., Ishikawa T., Yano M., Enomoto A., Nishimura H., et al. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 109 (1997) 458-463
20. Conti F., Frappier J., Dharancy S., Chereau C., Houssin D., Weill B., et al. Interleukin-15 production during liver allograft rejection in humans. Transplantation 76 (2003) 210-216
21. Agouridakis P., Kyriakou D., Alexandrakis M.G., Perisinakis K., Karkavitsas N., and Bouros D. Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest 32 (2002) 862-867
22. Ogawa M., Hirota M., Hayakawa T., Matsuno S., Watanabe S., Atomi Y., et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas 25 (2002) 325-330
23. Balthazar E.J., Robinson D.L., Megibow A.J., and Ranson J.H. Acute pancreatitis: value of CT in establishing prognosis. Radiology 174 (1990) 331-336
24. Ranson J.H., Rifkind K.M., Roses D.F., Fink S.D., Eng K., and Spencer F.C. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 139 (1974) 69-81
25. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
26. Lusted L.B. Decision-making studies in patient management. N Engl J Med 284 (1971) 416-424
27. Robertson E.A., and Zweig M.H. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem 27 (1981) 1569-1574
28. Triester S.L., and Kowdley K.V. Prognostic factors in acute pancreatitis. J Clin Gastroenterol 34 (2002) 167-176
29. Yadav D., Agarwal N., and Pitchumoni C.S. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 97 (2002) 1309-1318
30. Sugiura T., Harigai M., Kawaguchi Y., Takagi K., Fukasawa C., Ohsako-Higami S., et al. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int Immunol 14 (2002) 917-924
31. Suzuki A., McCall S., Choi S.S., Sicklick J.K., Huang J., Qi Y., et al. Interleukin-15 increases hepatic regenerative activity. J Hepatol 45 (2006) 410-418
32. Shinozaki M., Hirahashi J., Lebedeva T., Liew F.Y., Salant D.J., Maron R., et al. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest 109 (2002) 951-960
33. Li B., Sun R., Wei H., Gao B., and Tian Z. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 43 (2006) 1211-1219
34. Hiromatsu T., Yajima T., Matsuguchi T., Nishimura H., Wajjwalku W., Arai T., et al. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J Infect Dis 187 (2003) 1442-1451
35. Obermeier F., Hausmann M., Kellermeier S., Kiessling S., Strauch U.G., Duitman E., et al. IL-15 protects intestinal epithelial cells. Eur J Immunol 36 (2006) 2691-2699